REVA Receives Approval for Clinical Trial SAN DIEGO and SYDNEY, Australia, May 23, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce it has received regulatory approval from the German...

Access to 2011 Annual Meeting SAN DIEGO and SYDNEY, Australia, May 16, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold its 2011 Annual General Meeting of Stockholders on 23 May 2011, at...

REVA Expands Management Team With Key Executive Hire SYDNEY, Australia and SAN DIEGO, Feb. 25, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company"), which is developing a novel bioresorbable slide and lock drug-eluting...

REVA Closes A$85 Million IPO SAN DIEGO and SYDNEY, Australia, Dec. 21, 2010 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Initial Public Offering (the Offer) has...